John Pimanda

25PUBLICATIONS
152CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursMedical mycologyMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|May 14, 2026
PU.1 inflames lower-risk MDS.

|Apr 20, 2026
Genomic evolution and natural history of myeloproliferative neoplasms on therapy.

|Oct 08, 2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.

Dorien Pastoors, Marije Havermans, Roger Mulet-Lazaro

|May 13, 2025
Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.

Julie A I Thoms, Feng Yan, Henry R Hampton

|Oct 10, 2024
Seeing MDS through the lens of genomics.

Lachlin Vaughan, John E Pimanda

|Aug 28, 2024
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells.

Peter Truong, Sylvie Shen, Swapna Joshi

Pageof 5

Frequent Collaborators

11 joint publications

Julie A I Thoms

5 joint publications

Ashwin Unnikrishnan

4 joint publications

David J Curtis

3 joint publications

Stefan K Bohlander